Shares of EV Biologics, Inc. (OTCMKTS:YECO – Get Free Report) rose 13.5% during trading on Tuesday . The company traded as high as $0.30 and last traded at $0.30. Approximately 150 shares were traded during trading, a decline of 90% from the average daily volume of 1,548 shares. The stock had previously closed at $0.26.
EV Biologics Stock Up 13.5 %
The firm’s fifty day simple moving average is $0.26 and its 200 day simple moving average is $0.46.
About EV Biologics
EV Biologics, Inc, a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces.
Featured Articles
- Five stocks we like better than EV Biologics
- Stock Splits, Do They Really Impact Investors?
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- Dividend Capture Strategy: What You Need to Know
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- What is the Dogs of the Dow Strategy? Overview and Examples
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for EV Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EV Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
